38 Stocks Moving in Thursday's Pre-Market Session

Gainers

  • Birks Group Inc. BGI rose 150.4% to $2.00 in pre-market trading after the company reported a 12.2% year-over-year growth in FY20 sales.
  • CynergisTek, Inc. CTEK rose 41.1% to $2.40 in pre-market trading after the company announced it secured roughly $950,000 in renewals.
  • Infinity Pharmaceuticals, Inc. INFI shares rose 40.4% to $1.46 in pre-market trading after the company was granted Australian patent titled ‘Treatment of cancers using PI3 kinase isoform modulators.’
  • Dolphin Entertainment, Inc. DLPN shares rose 28% to $1.37 in pre-market trading after gaining over 10% on Wednesday.
  • Myomo, Inc. MYO rose 27% to $4.70 in pre-market trading after the company highlighted the launch of MyoCare, a program to provide enhanced support to first-year users of MyoPro powered brace.
  • OptiNose Inc OPTN rose 22.4% to $5.20 in pre-market trading after the company announced it signed an agreement with kaleo to co-promote XHANCE.
  • Qudian Inc. QD rose 22.1% to $3.20 in pre-market trading after jumping over 36% on Wednesday.
  • EXFO Inc. EXFO rose 19.6% to $3.85 in pre-market trading after the company reported better-than-expected Q3 sales.
  • Bionano Genomics, Inc. BNGO rose 18.7% to $0.56 in pre-market trading.
  • Acer Therapeutics Inc. ACER rose 16.5% to $3.75 in pre-market trading after the company reported its ACER-001, based on modeling data, may improve disease management in patients with urea cycle disorders compared to currently approved treatments requiring administration with food.
  • Bluecity Holdings BLCT rose 15.7% to $27.10 in pre-market trading. Bluecity shares surged 46% on Wednesday after the company priced its IPO at $16 per ADS.
  • Cheetah Mobile Inc. CMCM rose 14.8% to $2.72 in pre-market trading after climbing more than 30% on Wednesday.
  • Ocugen, Inc. OCGN rose 14.8% to $0.24 in pre-market trading.
  • Applied DNA Sciences, Inc. APDN rose 14% to $9.14 in pre-market trading after the company reported formation of clinical testing subsidiary to maximize utility of the FDA emergency use authorization-approved linea coronavirus assay Kit.
  • Landcadia Holdings II, Inc. LCA rose 12.8% to $13.87 in pre-market trading.
  • UP Fintech Holding Limited TIGR rose 10.3% to $7.61 in pre-market trading after jumping over 25% on Wednesday.
  • Osmotica Pharmaceuticals PLC OSMT rose 10.1% to $7.00 in pre-market trading after the company received the FDA approval for Upneeq™ (oxymetazoline hydrochloride ophthalmic solution), 0.1% for acquired blepharoptosis (droopy eyelid) in adults.
  • Veritone, Inc. VERI shares rose 9.9% to $13.35 in pre-market trading after the company raised its Q2 guidance.
  • NetEase, Inc. NTES rose 9.1% to $496.00 in pre-market trading.
  • Niu Technologies NIU rose 8.7% to $24.92 in pre-market trading.
  • NIO Inc. NIO rose 8.5% to $13.98 in pre-market trading.
  • Novan, Inc. NOVN rose 7.9% to $0.5330 in pre-market trading.
  • SAP SE SAP rose 7.3% to $157.73 in pre-market trading after the company reported an 8% rise in Q2 non-IFRS operating profit and reaffirmed its FY20 guidance.
  • Nikola Corporation NKLA rose 7.2% to $57.90 in pre-market trading. Nikola shares jumped more than 34% on Wednesday after JP Morgan upgraded the company's stock from Neutral to Overweight and announced a $45 price target.
  • Sibanye Stillwater Limited SBSW rose 7% to $10.35 in pre-market trading.
  • Marathon Patent Group, Inc. MARA rose 7% to $1.07 in pre-market trading after gaining 11% on Wednesday.
  • CHF Solutions, Inc. CHFS rose 6.1% to $0.61 in pre-market trading. On Wednesday, CHF Solutions and RenalSense announced a distribution partnership to offer ultrafiltration and real-time diagnostics.
  • Xeris Pharmaceuticals, Inc. XERS rose 5.7% to $2.79 in pre-market trading.

 

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Hudson Capital Inc. HUSN fell 12.2% to $0.7370 in pre-market trading after gaining over 32% on Wednesday.
  • Bed Bath & Beyond Inc. BBBY fell 10.3% to $9.34 in pre-market trading after the company reported a wider-than-expected loss for its first quarter and announced plans to close 200 stores in the next two year.
  • NanoViricides, Inc. NNVC shares fell 8.9% to $7.95 in pre-market trading. NanoViricides priced its 1.37 million share offering at $7.30 per share.
  • Otonomy Inc OTIC fell 7.3% to $3.30 in pre-market trading after the company disclosed a proposed public offering.
  • Unum Therapeutics Inc. UMRX fell 7.1% to $2.75 in pre-market trading after jumping about 24% on Wednesday.
  • Ideanomics, Inc. IDEX fell 7.1% to $1.45 in pre-market trading following a 24% surge on Wednesday.
  • BIOLASE, Inc. BIOL fell 6.5% to $0.4110 in pre-market trading. On Wednesday, BIOLASE disclosed that its Hygiene laser has met CDC guidelines to minimize the risk of COVID-19 transmission.
  • National Grid plc NGG fell 6.2% to $53.82 in pre-market trading.
  • Vislink Technologies, Inc. VISL shares fell 5.9% to $0.5839 in pre-market trading after gaining over 5% on Wednesday.
  • MYOS RENS Technology Inc. MYOS fell 5.4% to $1.40 in pre-market trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasHealth CarePharmaceuticalsPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!